Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Skin Neoplasms × Surgical Procedures, Operative × Clear all

Phase

Status

Completed 3 Withdrawn 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 11 Rectal Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 8 Sarcoma 8 Breast Neoplasms 7 Stomach Neoplasms 6 Esophageal Neoplasms 6 Lung Neoplasms 5 Hypopharyngeal Neoplasms 5 Carcinoma, Hepatocellular 5 Recurrence 4 Prostatic Neoplasms 4 Oropharyngeal Neoplasms 4 Neoplasms 4 Neoplasm Metastasis 4 Thyroid Neoplasms 3 Pancreatic Neoplasms 3 Nasopharyngeal Carcinoma 3 Melanoma 3 Laryngeal Neoplasms 3 Head and Neck Neoplasms 3 Glioma 3 Glioblastoma 3 Colonic Neoplasms 3 Urinary Bladder Neoplasms 2 Osteosarcoma 2 Mouth Neoplasms 2 Hyperthermia 2 Fallopian Tube Neoplasms 2 Endometrial Neoplasms 2

Interventions

pembrolizumab 8 Nivolumab 6 Ipilimumab 6 cemiplimab 4 aldesleukin 3 Interleukin-2 3 Blood Specimen Collection 3 lifileucel 2 fludarabine 2 Specimen Handling 2 HhAntag691 2 Cyclophosphamide 2 Biopsy 2 trametinib 1 spartalizumab 1 sonidegib 1 pertuzumab 1 four-arm poly(ethylene oxide)-b-poly(2-(diethylamino)ethyl methacrylate) 1 fludarabine phosphate 1 dabrafenib 1 brodalumab 1 atezolizumab 1 Vitamin A 1 Trastuzumab 1 Tissue Banks 1 Surgical Procedures, Operative 1 Standard of Care 1 Second Harmonic Generation Microscopy 1 Resistance Training 1 Red Light 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05794035 2023-11-30

IMPACTE-01

Assistance Publique - Hôpitaux de Paris

Phase NA Recruiting

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡